FDA OKs emergency use for Moderna, Pfizer COVID bivalent jabs

Raphael Bosano, ABS-CBN News

MANILA — The Department of Health (DOH) confirmed Tuesday that bivalent vaccines by Moderna and Pfizer against COVID-19 have been granted emergency use authority (EUA) by the Food and Drug Administration (FDA).<ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/news/12/26/22/presence-of-covid-bf7-subvariant-in-ph-should-spark-concern-expert">Presence of omicron subvariant BF.7 in PH should spark concern - expert</a></li></ul>Speaking to reporters, DOH OIC Maria Rosario Vergeire said the EUA was granted last week along with recommendations made by the Health Technology Assessment Council. DOH is expected to release in the coming days the recommendation as well as the guidelines for the priority population.Compared to the monovalent vaccines designed to combat the original SARS-COV2 that emerged in Wuhan, China at the latter part of 2019, the bivalent vaccines now provide protection against severe disease from caused by newer variants.“This bivalent vaccine has this component which addresses Omicron and its subvariants. But siyempre nag-e-evolve pa rin yung pag-aaral ng mga scientists,” she said.While no specific date has been given by the agency, the DOH has earlier said the procurement of bivalent vaccines are projected by the first quarter of 2023.“We are pursuing the procurement of bivalent vaccines, because articles and evidences have shown na ito ay mas makakaprotect sa ating kababayan because of component on Omicron variant,” Vergeire said.

DOH OIC Maria Rosario Vergeire said the EUA was granted last week along with recommendations made by the Health Technology Assessment Council. 

FDA OKs emergency use for Moderna, Pfizer COVID bivalent jabs | ABS-CBN

Entertainment

News

Metro.Style

Sports

More

News

FDA OKs emergency use for Moderna, Pfizer COVID bivalent jabs

FDA OKs emergency use for Moderna, Pfizer COVID bivalent jabs

Raphael Bosano,

ABS-CBN News

Published Dec 27, 2022 07:20 PM PHT

Read More:

DOH

COVID-19

bivalent vaccines

Moderna

Pfizer

Department of Health

Maria Rosario Vergeire

ABS-CBN is the leading media and entertainment company in the Philippines, offering quality content across TV, radio, digital, and film. Committed to public service and promoting Filipino values, ABS-CBN continues to inspire and connect audiences worldwide.

Corporate

Investors

Governance

International Distribution

Corporate

Governance

Investors

International Distribution

NPC Seal of Registration

Privacy Policy

Terms of Service

Advertise with Us

© 2024 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Advertise with Us

Privacy Policy

Terms of Service

© 2024 ABS-CBN Corporation. All Rights Reserved.